Cost-effectiveness of antiplatelet therapies.
Schleinitz
M D
MD
D003362:Cost-Benefit Analysis; D016527:Drug Costs / Q000706:statistics & numerical data / Q000639:trends; D005252:Fees, Pharmaceutical / Q000706:statistics & numerical data / Q000639:trends; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000191:economics*; D013557:Switzerland; D014481:United States
D010975:Platelet Aggregation Inhibitors